Search Results
98 results
Your search is now limited to «Prostate Cancer» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
04/22/2019 08:37
The Global Prostate Cancer Diagnostics Market research report 2019 primarily highlights market standing and forecast, categorizes the world Prostate Cancer Diagnostics market size (value & volume) by makers such as Genomic Health, Abbott, OPKO, Siemens Healthcare, DiaSorin, bioMeriux, Roche, MDx Health, Beckman Coulter, Myriad Genetics, Ambry Genetics, type, application, and region.prostate cancer diagnostics market study focuses on major leading industry players with information such as company profiles, product description and specification, scope, stock, price, revenue, and associated information.
04/08/2019 09:44
The world Health Day, a global health awareness event, was commemorated on April 7. The date, which incidentally coincides with the founding of the World Health Organisation in 1948, has this year’s theme as Universal Health Coverage for all. The theme became imperative as millions of people all over the world especially the developmentally challenged nations of the world; still had no access to basic healthcare. As part of its corporate social responsibility, the National Association of Seadogs, Pyrates Confraternity, long...
04/03/2019 03:14
SAN DIEGO, April 2, 2019/PRNewswire / -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today presented early data from its ongoing Phase 2 study evaluating Onvansertib in combination with Zytiga® (abiraterone acetate)/prednisone in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC).
04/03/2019 01:03
New and innovative ways of treating prostate cancer could be available to patients within five years, following an announcement today that scientists will receive a $12 million funding boost from the Australian Government and the Movember Foundation.
04/03/2019 01:03
New treatments for prostate cancer on the horizon after $12 million funding boost PRESS RELEASE - Wednesday April 3, 2019 New and innovative ways of treating prostate cancer could be available to patients within five years, following an announcement today that scientists will receive a $12 million funding boost from the Australian Government and the Movember Foundation.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications